Not applicableNot Yet RecruitingNCT06773377What this trial is testingStudy of the Prognostic Impact of CD44 on Renal Cell CarcinomaWho this might be right forRenal Cell Cancer Assiut University 77
Not applicableLooking for participantsNCT06676527What this trial is testingVorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell CarcinomaWho this might be right forNeoplasmsKidney NeoplasmsUrologic Neoplasms+10 more Jinling Hospital, China 39
Not applicableStudy completedNCT00849186What this trial is testingSunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney CancerWho this might be right forKidney Cancer Roswell Park Cancer Institute 20
Large-scale testing (Phase 3)Study completedNCT04987203What this trial is testingStudy to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma AVEO Pharmaceuticals, Inc. 343
Testing effectiveness (Phase 2)Study completedNCT01727089What this trial is testingBevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer+2 more National Cancer Institute (NCI) 59
Testing effectiveness (Phase 2)Study completedNCT03029780What this trial is testingAn Investigational Immuno-Therapy Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Bristol-Myers Squibb 104
Testing effectiveness (Phase 2)Looking for participantsNCT06413680What this trial is testingA First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their BodyWho this might be right forMelanomaClear-Cell Renal-Cell Carcinoma (ccRCC)Advanced Solid Tumors Regeneron Pharmaceuticals 240
Testing effectiveness (Phase 2)Looking for participantsNCT03786796What this trial is testingStudy of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene MutationsWho this might be right forRenal Cell CarcinomaMetastatic Renal Cell CarcinomaKidney Cancer+2 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Testing effectiveness (Phase 2)Study completedNCT02432846What this trial is testingIntratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC)Who this might be right forRenal Cell Carcinoma, Metastatic Mendus 88
Large-scale testing (Phase 3)Study completedNCT00334282What this trial is testingSafety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell CarcinomaWho this might be right forCarcinoma, Renal Cell GlaxoSmithKline 435
Not applicableUnknownNCT04669613What this trial is testingContrast Ultrasound Dispersion Imaging (CUDI) as a Diagnostic Modality in the Diagnosis of Renal Cell CarcinomaWho this might be right forKidney Cancer Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 10
Testing effectiveness (Phase 2)Looking for participantsNCT06638931What this trial is testingAgnostic Therapy in Rare Solid TumorsWho this might be right forUrachal CancerParathyroid CarcinomaFibrolamellar Carcinoma+38 more Instituto do Cancer do Estado de São Paulo 28
Testing effectiveness (Phase 2)Study completedNCT00465179What this trial is testingSunitinib Malate in Patients With Non-Clear Cell Renal Cell CancerWho this might be right forRenal Cell CancerKidney Cancer M.D. Anderson Cancer Center 61
Not applicableStudy completedNCT04669366What this trial is testingTreatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National RegistriesWho this might be right forKidney Neoplasms Pfizer 1,205
Testing effectiveness (Phase 2)Looking for participantsNCT07239596What this trial is testingPhase Ib/II Clinical Study of SHR-8068 Combined Anti-tumor Drugs in the Treatment of Advanced Renal Cell CarcinomWho this might be right forAdvanced Renal Cell Carcinoma Suzhou Suncadia Biopharmaceuticals Co., Ltd. 92
Testing effectiveness (Phase 2)Active Not RecruitingNCT06307431What this trial is testingAdjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).Who this might be right forRenal Cell Carcinoma Merck Sharp & Dohme LLC 272
Testing effectiveness (Phase 2)Study completedNCT02187302What this trial is testingCRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)Who this might be right forMetastatic Renal Cell Carcinoma NewLink Genetics Corporation 115
Large-scale testing (Phase 3)Looking for participantsNCT05770037What this trial is testingDETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive CancersWho this might be right forHaematological MalignancyMalignant NeoplasmLymphoproliferative Disorders+8 more Cancer Research UK 30
Testing effectiveness (Phase 2)Ended earlyNCT01185366What this trial is testingEverolimus Versus Sunitinib in Non-Clear Cell Renal Cell CarcinomaWho this might be right forKidney Cancer M.D. Anderson Cancer Center 73
Testing effectiveness (Phase 2)UnknownNCT01240005What this trial is testingCytokine Induced Killer Cells Stimulated by DC Immunotherapy for Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Qingdao University 30